VA
MGNX icon

Verdad Advisers’s MacroGenics MGNX Stock Holding History

Verdad Advisers’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.7K Buy
+14,431
New +$54.6K 0.06% 196

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Verdad Advisers's MGNX Position: Q2 2026 in Review

Verdad Advisers opened a new position in MacroGenics (MGNX) in Q2 2026: 14,431 shares worth $66.7K. The stake represents 0.06% of the portfolio and ranks #196 among its holdings.

122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Verdad Advisers held 14,431 shares of MacroGenics worth $66.7K as of Q2 2026.
  • MacroGenics was a new Verdad Advisers position in Q2 2026.
  • MacroGenics made up 0.06% of Verdad Advisers's portfolio in Q2 2026, its #196 holding.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Verdad Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.